Bifidobacterium breve strain FDAARGOS_561

Bifidobacterium breve strain FDAARGOS_561 is a Gram-positive, anaerobic bacterium predominantly found in the gastrointestinal tract, particularly within the microbiota of healthy newborns. This strain is notably present in human breast milk and the intestines of infants, where it plays a crucial role in shaping the gut microbiota during early development. Bifidobacterium species, including B. breve, are recognized for their beneficial effects on gut health, contributing to the establishment of a balanced microbiota in infants. The anaerobic nature of B. breve indicates its adaptation to low-oxygen environments, such as those found in the gut, where it thrives alongside other microbial communities. The presence of this strain in breast milk underscores its potential role in fostering a healthy microbiome in infants, as breast milk serves as a vital source of nutrients and beneficial microbes during the early stages of life. Furthermore, the ability of B. breve to inhabit both breast milk and the gastrointestinal tract suggests a co-evolutionary relationship that may enhance the infant's immune development and metabolic functions. This unique ecological niche highlights the importance of B. breve in supporting the health and well-being of newborns, providing insights into the critical interactions between diet, microbiota, and host health during infancy.